Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | F7 | P08709 | 3/20 | 0.50 |
| ▸ | F3 | P13726 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538853 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL1301319 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4339464 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4335893 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL5166020 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL8695877 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL25327373 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL4341933 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL6438450 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA | |
| SCHEMBL2931992 | 1.00 | ALDH1A1 (0.50) | ALDH1A1F7F3CYP19A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734932-A1 | ORGANIC COMPOUNDS AND THEIR USE FOR GENERATING A FRAGRANT ALCOHOL | Givaudan SA (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| EP-4602141-A1 | A FRAGRANCE MIXTURE (VI) | Symrise AG (DE) | 2025-08-20 | — | — | EP | claimed |
| CN-120078656-A | Fragrance durability improver and preparation method thereof, essence and shampoo product | 森富(广东)科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-119968452-A | Perfume mixture (VI) | 西姆莱斯股份公司 | 2025-05-09 | — | — | CN | claimed |
| US-20250134790-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2025-05-01 | — | — | US | claimed |
| US-6077821-A | FOR USE IN DELIVERING SUSTAINED RELEASE OR ENHANCED LONGEVITY FRAGRANCES TO A VARIETY OF PERSONAL CARE AND PERSONAL HYGIENE PRODUCTS INTER ALIA DEODORANTS, BODY LOTIONS OR CREAMS, AND SHAMPOOS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-20 | — | — | US | claimed |
| US-6054547-A | POLYETHERSILOXANE COPOLYMERS | GENERAL ELECTRIC COMPANY (US) | 2000-04-25 | — | — | US | claimed |
| US-6046156-A | Fragrance releasing olefinic silanes | GENERAL ELECTRIC COMPANY (US) | 2000-04-04 | — | — | US | claimed |
| EP-0982313-A2 | Fragrance releasing olefinic silanes | GENERAL ELECTRIC COMPANY (US) | 2000-03-01 | — | — | EP | claimed |
| EP-0982022-A2 | Fragrance releasing non-volatile polymeric siloxanes | GENERAL ELECTRIC COMPANY (US) | 2000-03-01 | — | — | EP | claimed |
| US-6013618-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS | PROCTER & GAMBLE COMPANY (US) | 2000-01-11 | — | — | US | claimed |
| US-5919752-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS. | PROCTER & GAMBLE (US) | 1999-07-06 | — | — | US | claimed |
| EP-0282951-B1 | Controlled release preparations of active materials | NIPPON OILS & FATS CO LTD (JP) | 1994-01-12 | — | — | EP | claimed |
| EP-0282951-A2 | Controlled release preparations of active materials | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1988-09-21 | — | — | EP | claimed |
| US-4152422-A | Attractant for male Mediterranean fruit fly | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1979-05-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | ALDH1A1 952/4885F7 1036/4885F3 2716/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | ALDH1A1 1377/4885F7 831/4885F3 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.